StockGlow

Newron Pharmaceuticals S.p.A. (NP5.F)

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

12.60+0.04%Healthcare
Compare NP5.F with
StockGlow Score
11
Bearish
BearishBullish
1 year ago+75.7%

The outlook

Newron Pharmaceuticals S.p.A. currently reads as bearish based on below its 50- & 200-day averages, 21% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range21% of the way from its 52-week low to high
Market cap
$262.2M
52-wk high
33.55
52-wk low
7.01
50-day avg
13.34
200-day avg
18.03
Trailing P/E
—

Similar stocks

NP5.DENewron Pharmaceuticals S.p.A.$12.95+0.00%NWRN.SWNewron Pharmaceuticals S.p.A.$11.94+1.19%NPAU.FBetterLife Pharma Inc.$0.14+14.52%88Q.DE4basebio PLC$5.55+0.00%NSGB.FNet Insight AB (publ)$0.19+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy